Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial
Titel:
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial
Auteur:
Shaw, Alice T Gandhi, Leena Gadgeel, Shirish Riely, Gregory J Cetnar, Jeremy West, Howard Camidge, D Ross Socinski, Mark A Chiappori, Alberto Mekhail, Tarek Chao, Bo H Borghaei, Hossein Gold, Kathryn A Zeaiter, Ali Bordogna, Walter Balas, Bogdana Puig, Oscar Henschel, Volkmar Ou, Sai-Hong Ignatius